SSG
AURA icon

Summit Securities Group’s Aura Biosciences AURA Stock Holding History

Summit Securities Group’s Portfolio AURA Stock Details AURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-750
Closed -$11K – 924
2022
Q2 		$11K Buy
+750
New +$12.4K ﹤0.01% 828

Other funds holding AURA

MCMC
Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return
MVM
Medicxi Ventures Management St. Helier, Jersey $982M AUM 210.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Summit Securities Group's AURA Position: Q3 2022 in Review

Summit Securities Group sold out of Aura Biosciences (AURA) in Q3 2022, closing a stake of 750 shares — an estimated $11K sold.

Summit Securities Group first reported a position in AURA in Q2 2022 and held it in 1 quarter. The position peaked at $11K in Q2 2022. 43 funds tracked by Wall St. Rank hold AURA as of Q3 2022.

  • Summit Securities Group reported no remaining Aura Biosciences position as of Q3 2022 after selling out during the quarter.
  • Summit Securities Group sold 750 Aura Biosciences shares in Q3 2022, an estimated $11K.
  • Summit Securities Group first reported a position in Aura Biosciences in Q2 2022 and held it in 1 quarter.
  • Summit Securities Group's Aura Biosciences position peaked at $11K in Q2 2022.
  • 43 funds tracked by Wall St. Rank held Aura Biosciences as of Q3 2022.

Based on Summit Securities Group's 13F filing for Q3 2022, filed 2 Nov 2022.